EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nitrofurantoin as a preferred first-line therapy for urinary tract infection: A comparison using urinary tract infection-specific antibiograms

Colby P Souders, Andrew Clark, Bonnie C Prokesch, Philippe E Zimmern

Bladder · 2025

DOI: 10.14440/bladder.0018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bladder, 2025. Verfasst von Colby P Souders und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, United States of America. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Local antibiograms are a highly useful tool to guide empiric antibiotic therapy for a variety of infections.

Objectives

This study compares nitrofurantoin (NF) susceptibility in outpatient urine isolates using antibiogram data from two United States academic medical centers.

Methods

In this brief report, we compare antibiograms of urinary isolates from two distinct academic institutions—the University of Texas Southwestern (UTSW) in Dallas, Texas, and the University of Kansas Medical Center (KU) in Kansas City, Kansas—focusing on the most common uropathogens susceptible to NF to evaluate whether NF remains an appropriate first-line agent for uncomplicated cystitis.

Results

For the 2022 antibiogram, KU tested 5,524 urinary isolates and UTSW tested 2,530 urinary isolates. The susceptibility data were consistent across the two institutions, suggesting that NF can continue to be considered a first-line therapy for uncomplicated urinary tract infections in women.

Conclusion

This report highlights the importance of clinicians consulting their local antibiograms to inform empiric antibiotic therapy.

Schlagwörter

Stichwörter der Autor:innen

AntibiogramEmpiric therapyNitrofurantoinUrinary tract infection

Autor:innen und Institutionen

  • Department of Urology, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, United States of America.
  • Department of Pathology, School of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America.
  • Department of Infectious Disease, School of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America.
  • Department of Urology, School of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Souders, C. P., Clark, A., Prokesch, B. C., & Zimmern, P. E. (2025). Nitrofurantoin as a preferred first-line therapy for urinary tract infection: A comparison using urinary tract infection-specific antibiograms. Bladder. https://doi.org/10.14440/bladder.0018

Vancouver

Souders CP, Clark A, Prokesch BC, Zimmern PE. Nitrofurantoin as a preferred first-line therapy for urinary tract infection: A comparison using urinary tract infection-specific antibiograms. Bladder. 2025. doi:10.14440/bladder.0018

BibTeX
@article{Souders2025,
  author = {Souders, Colby P and Clark, Andrew and Prokesch, Bonnie C and Zimmern, Philippe E},
  title = {Nitrofurantoin as a preferred first-line therapy for urinary tract infection: A comparison using urinary tract infection-specific antibiograms},
  journal = {Bladder},
  year = {2025},
  doi = {10.14440/bladder.0018}
}
Kostenlos starten →